Ekaterina Krauss

Ipsen (France) — France

Medicine · Health Sciences

16h-index1.4kcitations80works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(37), Inflammatory Bowel Disease(10), Chronic Obstructive Pulmonary Disease (COPD) Research(8), Respiratory and Cough-Related Research(7), Microscopic Colitis(7)

Publications79 total

Targeting fused in sarcoma (FUS): a novel antisense strategy for treating idiopathic pulmonary fibrosis
Signal Transduction and Targeted Therapy·2026Open Access
Peri-Transplant Frailty Changes Impact Survival in Interstitial Lung Diseases
ERJ Open Research·2026Open Access
Sex-specific phenotypes and outcomes in non‑IPF interstitial lung disease: results from the INSIGHTS‑ILD registry
Respiration·2026Open Access
RAAS antagonists dampen the SARS-CoV-2 infection in ex-vivo cultured human precision-cut lung slices
Respiratory Research·2026Open Access
Additional file 1 of RAAS antagonists dampen the SARS-CoV-2 infection in ex-vivo cultured human precision-cut lung slices
Figshare·2026Open Access
Additional file 1 of RAAS antagonists dampen the SARS-CoV-2 infection in ex-vivo cultured human precision-cut lung slices
Figshare·2026Open Access
RAAS antagonists dampen the SARS-CoV-2 infection in ex-vivo cultured human precision-cut lung slices
Figshare·2026Open Access
RAAS antagonists dampen the SARS-CoV-2 infection in ex-vivo cultured human precision-cut lung slices
Figshare·2026Open Access
The Patient Journey in Interstitial Lung Disease: Mobility, Independence, and Psychological Burden
Journal of Clinical Medicine·2025Open Access
Pulmonary Hypertension Drives Prognosis in Idiopathic Pulmonary Fibrosis: Insights from the European IPF Registry
Journal of Clinical Medicine·2025Open Access
Antisence Oligonucleotide Silencing of Fused in Sarcoma (FUS): A Novel Therapeutic Intervention for Idiopathic Pulmonary Fibrosis
2025
Impact of Peri-Transplant Frailty (Clinical Frailty Scale, CFS) on Survival after Lung Transplant in Interstitial Lung Disease (ILD): Insights from the Lung Transplant- and European IPF Registry (eurIPFreg)
Transplantation·2025
Real-world evidence from the INSIGHTS-ILD registry: Impact of INBUILD criteria on disease progression and therapy modifications
2025
Digital Health in ILD: Assessing Adherence to the Self-Assessment Algorithm in the European ILD Registry (eurILDreg ASA-ILD)
2025
Dual Impacts of Lung Transplantation on the Recovery and Comorbidity of Interstitial Lung Diseases: A Longitudinal Assessment of the Benefits and Burden
Journal of Clinical Medicine·2025Open Access
Ein neues Kapitel in der Therapie der Lungenfibrose
Pneumo News·2025
Antisence Oligonucleotide Silencing of Fused in Sarcoma (FUS): A Novel Therapeutic Intervention for Idiopathic Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine·2025
Impact of Lung Transplantation on Frailty: A Longitudinal Analysis from the Lung Transplant and European ILD Registry (eurILDreg)
American Journal of Respiratory and Critical Care Medicine·2025
LC3B Interactome in Alveolar Epithelial Cells: Novel Insights of Autophagy Regulation in Lung Fibrosis
American Journal of Respiratory and Critical Care Medicine·2025
Real-life characteristics and management of patients with fibrosing interstitial lung disease: INSIGHTS-ILD registry
ERJ Open Research·2025· 3 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Werner Seeger(24), Andreas Güenther(22), Silke Tello(17), Bruno Crestani(14), Poornima Mahavadi(10), Carlo Vancheri(9), Fotios Drakopanagiotakis(9), Ruth C. Dartsch(9), Martina Korfei(9), Philippe Bonniaud(7), Athol U. Wells(7), Jonas Mudter(6), Maria Degen(6), Jochen Wilhelm(6), Andreas Guenther(6), Marion Frankenberger(5), Francesco Bonella(4), Christian Grohé(4), Heinrike Wilkens(4), Dirk Koschel(4)